Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study

Fig. 3

Quantitative profiles of the AMM (median, μM) in serum samples of three groups: healthy subjects, the ACI patients, and the CCI patients. Note: the outlying level of p-HPhLA in the ACI group is 1.4 μM. BA benzoic acid, PhPA phenylpropionic acid, PhLA phenyllactic acid, p-HPhAA p-hydroxyphenylacetic acid, p-HPhLA p-hydroxyphenyllactic acid

Back to article page

Critical Care

ISSN: 1364-8535